Curtailed two-stage design for comparing two arms in randomized phase II clinical trials

Research output: Contribution to journalArticle

Abstract

In phase II clinical trials, patients are recruited sequentially and consequently the time required to complete the clinical trial will become long if the accrual rate is low. To speed up the drug development process and account for ethical issues, stochastically and non-stochastically curtailed two-stage designs have been proposed in single-arm phase II clinical trials. More recently, randomized phase II clinical trials are being increasingly recommended to avoid biased evaluation of the treatment effect when compared with a historical control. The current patient population and the historical one may be quite heterogeneous. Moreover, it is impossible to randomly assign patients for treatments. Consequently, various two-stage designs have been presented for comparing two arms. Since the sample size required in a randomized phase II trial is usually larger than that required in a single-arm phase II trial, we introduce the concept of curtailed sampling procedure to develop curtailed two-stage design for two-armed, randomized phase II clinical trials. The proposed design does not require pairwise patient response comparison, yet it allows a trial to be stopped early as soon as the difference in therapeutic effect of the experimental therapy and the standard at the end of a trial is foreknown.

Original languageEnglish
Pages (from-to)939-950
Number of pages12
JournalJournal of Biopharmaceutical Statistics
Volume28
Issue number5
DOIs
Publication statusPublished - 2018 Sep 3

Fingerprint

Two-stage Design
Phase II Clinical Trials
Clinical Trials
Randomized Controlled Trials
Investigational Therapies
Therapeutic Uses
Ethics
Sample Size
Treatment Effects
Development Process
Therapy
Biased
Assign
Pairwise
Drugs
Speedup
Therapeutics
Pharmaceutical Preparations
Population
Evaluation

All Science Journal Classification (ASJC) codes

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{7e4c0c2328654b179ebd07c0994b2256,
title = "Curtailed two-stage design for comparing two arms in randomized phase II clinical trials",
abstract = "In phase II clinical trials, patients are recruited sequentially and consequently the time required to complete the clinical trial will become long if the accrual rate is low. To speed up the drug development process and account for ethical issues, stochastically and non-stochastically curtailed two-stage designs have been proposed in single-arm phase II clinical trials. More recently, randomized phase II clinical trials are being increasingly recommended to avoid biased evaluation of the treatment effect when compared with a historical control. The current patient population and the historical one may be quite heterogeneous. Moreover, it is impossible to randomly assign patients for treatments. Consequently, various two-stage designs have been presented for comparing two arms. Since the sample size required in a randomized phase II trial is usually larger than that required in a single-arm phase II trial, we introduce the concept of curtailed sampling procedure to develop curtailed two-stage design for two-armed, randomized phase II clinical trials. The proposed design does not require pairwise patient response comparison, yet it allows a trial to be stopped early as soon as the difference in therapeutic effect of the experimental therapy and the standard at the end of a trial is foreknown.",
author = "Chen, {Chia Min} and Yunchan Chi and Chang, {Hsing Ming}",
year = "2018",
month = "9",
day = "3",
doi = "10.1080/10543406.2018.1428615",
language = "English",
volume = "28",
pages = "939--950",
journal = "Journal of Biopharmaceutical Statistics",
issn = "1054-3406",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

Curtailed two-stage design for comparing two arms in randomized phase II clinical trials. / Chen, Chia Min; Chi, Yunchan; Chang, Hsing Ming.

In: Journal of Biopharmaceutical Statistics, Vol. 28, No. 5, 03.09.2018, p. 939-950.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Curtailed two-stage design for comparing two arms in randomized phase II clinical trials

AU - Chen, Chia Min

AU - Chi, Yunchan

AU - Chang, Hsing Ming

PY - 2018/9/3

Y1 - 2018/9/3

N2 - In phase II clinical trials, patients are recruited sequentially and consequently the time required to complete the clinical trial will become long if the accrual rate is low. To speed up the drug development process and account for ethical issues, stochastically and non-stochastically curtailed two-stage designs have been proposed in single-arm phase II clinical trials. More recently, randomized phase II clinical trials are being increasingly recommended to avoid biased evaluation of the treatment effect when compared with a historical control. The current patient population and the historical one may be quite heterogeneous. Moreover, it is impossible to randomly assign patients for treatments. Consequently, various two-stage designs have been presented for comparing two arms. Since the sample size required in a randomized phase II trial is usually larger than that required in a single-arm phase II trial, we introduce the concept of curtailed sampling procedure to develop curtailed two-stage design for two-armed, randomized phase II clinical trials. The proposed design does not require pairwise patient response comparison, yet it allows a trial to be stopped early as soon as the difference in therapeutic effect of the experimental therapy and the standard at the end of a trial is foreknown.

AB - In phase II clinical trials, patients are recruited sequentially and consequently the time required to complete the clinical trial will become long if the accrual rate is low. To speed up the drug development process and account for ethical issues, stochastically and non-stochastically curtailed two-stage designs have been proposed in single-arm phase II clinical trials. More recently, randomized phase II clinical trials are being increasingly recommended to avoid biased evaluation of the treatment effect when compared with a historical control. The current patient population and the historical one may be quite heterogeneous. Moreover, it is impossible to randomly assign patients for treatments. Consequently, various two-stage designs have been presented for comparing two arms. Since the sample size required in a randomized phase II trial is usually larger than that required in a single-arm phase II trial, we introduce the concept of curtailed sampling procedure to develop curtailed two-stage design for two-armed, randomized phase II clinical trials. The proposed design does not require pairwise patient response comparison, yet it allows a trial to be stopped early as soon as the difference in therapeutic effect of the experimental therapy and the standard at the end of a trial is foreknown.

UR - http://www.scopus.com/inward/record.url?scp=85041002737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041002737&partnerID=8YFLogxK

U2 - 10.1080/10543406.2018.1428615

DO - 10.1080/10543406.2018.1428615

M3 - Article

AN - SCOPUS:85041002737

VL - 28

SP - 939

EP - 950

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

SN - 1054-3406

IS - 5

ER -